amphetamine has been researched along with 2019 Novel Coronavirus Disease in 7 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 7 (100.00) | 2.80 |
Authors | Studies |
---|---|
Estévez-Danta, A | 1 |
Bijlsma, L | 1 |
Capela, R | 1 |
Cela, R | 1 |
Celma, A | 1 |
Hernández, F | 1 |
Lertxundi, U | 1 |
Matias, J | 1 |
Montes, R | 1 |
Orive, G | 1 |
Prieto, A | 1 |
Santos, MM | 1 |
Rodil, R | 1 |
Quintana, JB | 1 |
Hahn, RZ | 1 |
Bastiani, MF | 1 |
Lizot, LLF | 1 |
Schneider, A | 1 |
da Silva Moreira, IC | 1 |
Meireles, YF | 1 |
Viana, MF | 1 |
do Nascimento, CA | 1 |
Linden, R | 1 |
Psichoudaki, M | 1 |
Mina, T | 1 |
Savvidou, M | 1 |
Mina, C | 1 |
Michael, C | 1 |
Fatta-Kassinos, D | 1 |
Oertel, R | 1 |
Schubert, S | 1 |
Helm, B | 1 |
Mayer, R | 1 |
Dumke, R | 1 |
El-Armouche, A | 1 |
Renner, B | 1 |
Luo, J | 1 |
Bello, D | 1 |
Pagsuyoin, S | 1 |
Rockhill, KM | 1 |
Olson, R | 1 |
Dart, RC | 1 |
Iwanicki, JL | 1 |
Black, JC | 1 |
Mariottini, C | 1 |
Ojanperä, I | 1 |
Kriikku, P | 1 |
7 other studies available for amphetamine and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Use of illicit drugs, alcohol and tobacco in Spain and Portugal during the COVID-19 crisis in 2020 as measured by wastewater-based epidemiology.
Topics: Amphetamine; Cocaine; Communicable Disease Control; COVID-19; Humans; Illicit Drugs; Methamphetamine | 2022 |
Long-term monitoring of drug consumption patterns during the COVID-19 pandemic in a small-sized community in Brazil through wastewater-based epidemiology.
Topics: Amphetamine; Brazil; Caffeine; Cocaine; COVID-19; Dronabinol; Humans; Illicit Drugs; N-Methyl-3,4-me | 2022 |
Wastewater-based monitoring of illicit drugs in Cyprus by UPLC-MS/MS: The impact of the COVID-19 pandemic.
Topics: Amphetamine; Chromatography, Liquid; Cocaine; Communicable Disease Control; COVID-19; Cyprus; Humans | 2023 |
Drug consumption in German cities and municipalities during the COVID-19 lockdown: a wastewater analysis.
Topics: Amphetamine; Cities; Communicable Disease Control; Cotinine; COVID-19; Humans; Illicit Drugs; Metopr | 2023 |
Long-term wastewater-based surveillance and impacts of the COVID-19 pandemic on drug use trends in a U.S. Northeast rural town.
Topics: Amphetamine; Cocaine; COVID-19; Fentanyl; Humans; Hydrocodone; Methadone; N-Methyl-3,4-methylenediox | 2023 |
Differing Behaviors Around Adult Nonmedical Use of Prescription Stimulants and Opioids: Latent Class Analysis.
Topics: Adult; Amphetamine; Analgesics, Opioid; Central Nervous System Stimulants; Child; COVID-19; Cross-Se | 2023 |
Increase in drugs-of-abuse findings in post-mortem toxicology due to COVID-19 restrictions-First observations in Finland.
Topics: Amphetamine; Analgesics, Opioid; Autopsy; Buprenorphine; Cannabinoid Receptor Agonists; Central Nerv | 2021 |